Integrated Core Strategies (US) LLC 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-26 5:03 pm Sale |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Integrated Core Strategies (US) LLC | 785,854 2.000% |
-636,623 (-44.75%) |
Filing |
| 2022-05-31 4:40 pm Purchase |
2022-05-26 | 13G | Viridian Therapeutics, Inc. VRDN |
Integrated Core Strategies (US) LLC | 1,422,477 5.100% |
1,422,477 (New Position) |
Filing |